The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization

Vista sencilla de ítem
dc.contributor.authorDashti, Parisa
dc.contributor.authorvan de Peppel, Jeroen
dc.contributor.authorThaler, Roman
dc.contributor.authorParadise, Christopher R.
dc.contributor.authorStein, Gary S.
dc.contributor.authorMontecino, Martin A.
dc.contributor.authorvan Leeuwen, Johannes P.T.M.
dc.contributor.authorvan der Eerden, Bram J.
dc.contributor.authorDudakovic, Amel
dc.contributor.authorvan Wijnen, Andre J.
dc.date.accessioned2024-04-08T15:20:58Z
dc.date.available2024-04-08T15:20:58Z
dc.date.issued2023-01-30
dc.descriptionINDEXACIÓN: SCOPUS.
dc.description.abstractBone formation is controlled by histone modifying enzymes that regulate post-translational modifications on nucleosomal histone proteins and control accessibility of transcription factors to gene promoters required for osteogenesis. Enhancer of Zeste homolog 2 (EZH2/Ezh2), a histone H3 lysine 27 (H3K27) methyl transferase, is a suppressor of osteoblast differentiation. Ezh2 is regulated by SET and MYND domain-containing protein 2 (SMYD2/Smyd2), a lysine methyltransferase that modifies both histone and non-histone proteins. Here, we examined whether Smyd2 modulates Ezh2 suppression of osteoblast differentiation. Musculoskeletal RNA-seq data show that SMYD2/Smyd2 is the most highly expressed SMYD/Smyd member in human bone tissues and mouse osteoblasts. Smyd2 loss of function analysis in mouse MC3T3 osteoblasts using siRNA depletion enhances proliferation and calcium deposition. Loss of Smyd2 protein does not affect alkaline phosphatase activity nor does it result in a unified expression response for standard osteoblast-related mRNA markers (e.g., Bglap, Ibsp, Spp1, Sp7), indicating that Smyd2 does not directly control osteoblast differentiation. Smyd2 protein depletion enhances levels of the osteo-suppressive Ezh2 protein and H3K27 trimethylation (H3K27me3), as expected from increased cell proliferation, while elevating the osteo-inductive Runx2 protein. Combined siRNA depletion of both Smyd2 and Ezh2 protein is more effective in promoting calcium deposition when compared to loss of either protein. Collectively, our results indicate that Smyd2 inhibits proliferation and indirectly the subsequent mineral deposition by osteoblasts. Mechanistically, Smyd2 represents a functional epigenetic regulator that operates in parallel to the suppressive effects of Ezh2 and H3K27 trimethylation on osteoblast differentiation. © 2022 Elsevier B.V.
dc.identifier.doi10.1016/j.gene.2022.146928
dc.identifier.issnGene, Volume 851, 30 January 2023, Article number 146928
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/55750
dc.language.isoen
dc.publisherElsevier B.V.
dc.rights.licenseCC BY-NC-ND 4.0 DEED Atribución-NoComercial-SinDerivadas 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectBone
dc.subjectChromatin
dc.subjectEpigenetics
dc.subjectHistone
dc.subjectMineralization
dc.subjectOsteoblast
dc.subjectOsteogenesis
dc.titleThe lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
1-s2.0-S037811192200748X-main.pdf
Tamaño:
2.25 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS.
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista